Applications and prospects of biomaterials in diabetes management.

Wenhe Guan, Liang Zhang
Author Information
  1. Wenhe Guan: Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
  2. Liang Zhang: Department of Human Anatomy, School of Basic Medicine, Shenyang Medical College, Shenyang, Liaoning, China.

Abstract

diabetes is a widespread metabolic disorder that presents considerable challenges in its management. Recent advancements in biomaterial research have shed light on innovative approaches for the treatment of diabetes. This review examines the role of biomaterials in diabetes diagnosis and treatment, as well as their application in managing diabetic wounds. By evaluating recent research developments alongside future obstacles, the review highlights the promising potential of biomaterials in diabetes care, underscoring their importance in enhancing patient outcomes and refining treatment methodologies.

Keywords

References

  1. J Breath Res. 2015 Feb 26;9(1):016005 [PMID: 25719511]
  2. RSC Adv. 2018 Oct 21;8(62):35618-35624 [PMID: 30555687]
  3. ACS Sens. 2024 Nov 22;9(11):6148-6156 [PMID: 39531533]
  4. Front Immunol. 2023 Oct 23;14:1269960 [PMID: 37936689]
  5. Front Psychol. 2022 Jan 31;12:746217 [PMID: 35173644]
  6. ACS Appl Mater Interfaces. 2024 Aug 14;16(32):41869-41880 [PMID: 39101935]
  7. Sci Transl Med. 2024 Nov 27;16(775):eadp3611 [PMID: 39602507]
  8. Biomater Sci. 2023 Apr 11;11(8):2661-2677 [PMID: 36810436]
  9. Vision Res. 2023 Sep;210:108258 [PMID: 37244011]
  10. Expert Opin Ther Pat. 2020 Jun;30(6):433-452 [PMID: 32164470]
  11. ACS Appl Bio Mater. 2021 Dec 20;4(12):8129-8158 [PMID: 35005929]
  12. ACS Appl Mater Interfaces. 2022 Jan 12;14(1):2401-2410 [PMID: 34968024]
  13. Int J Nanomedicine. 2024 Jan 26;19:965-992 [PMID: 38293611]
  14. MEDICC Rev. 2021 Sep 17;24(1):44-58 [PMID: 34653116]
  15. Molecules. 2023 Jan 06;28(2): [PMID: 36677658]
  16. J Vis Exp. 2023 Jul 21;(197): [PMID: 37590545]
  17. Nanoscale. 2020 Jun 4;12(21):11395-11415 [PMID: 32432308]
  18. Turk J Med Sci. 2020 Apr 14;50(4):1180-1196 [PMID: 32283898]
  19. Expert Rev Endocrinol Metab. 2024 May;19(3):217-227 [PMID: 38693782]
  20. Int J Biol Macromol. 2024 Mar;261(Pt 1):129064 [PMID: 38161006]
  21. Polymers (Basel). 2024 Jun 27;16(13): [PMID: 39000680]
  22. Nat Biotechnol. 2019 Apr;37(4):389-406 [PMID: 30804534]
  23. Wound Repair Regen. 2022 Mar;30(2):232-244 [PMID: 35092133]
  24. Acta Biomater. 2023 Jan 1;155:1-18 [PMID: 36356914]
  25. Adv Wound Care (New Rochelle). 2024 Feb;13(2):97-113 [PMID: 37395488]
  26. Polymers (Basel). 2023 Jul 18;15(14): [PMID: 37514474]
  27. Small. 2024 Dec;20(49):e2406206 [PMID: 39268781]
  28. Drug Deliv Transl Res. 2025 Jan;15(1):216-230 [PMID: 38619705]
  29. Heliyon. 2023 Sep 15;9(9):e20201 [PMID: 37809635]
  30. Mar Drugs. 2022 Jan 24;20(2): [PMID: 35200625]
  31. Int J Mol Med. 2012 Oct;30(4):953-9 [PMID: 22859311]
  32. Mar Drugs. 2022 Aug 18;20(8): [PMID: 36005529]
  33. J Mater Chem B. 2024 Jan 31;12(5):1126-1148 [PMID: 38205636]
  34. ACS Sens. 2024 Jan 26;9(1):464-473 [PMID: 38153408]
  35. J Diabetes Res. 2023 May 24;2023:1399917 [PMID: 37265573]
  36. Chem Soc Rev. 2020 Nov 7;49(21):7671-7709 [PMID: 33020790]
  37. J Orthop Surg (Hong Kong). 2018 May-Aug;26(3):2309499018802486 [PMID: 30295168]
  38. Drug Deliv Transl Res. 2022 Sep;12(9):2157-2177 [PMID: 35763196]
  39. Curr Diabetes Rev. 2025;21(4):38-46 [PMID: 38310481]
  40. Sci Diabetes Self Manag Care. 2021 Aug;47(4):245-254 [PMID: 34036847]
  41. Diabetes Ther. 2018 Aug;9(4):1713-1718 [PMID: 29808361]
  42. J Chromatogr A. 2022 Dec 6;1685:463564 [PMID: 36323098]
  43. Biomater Transl. 2022 Sep 28;3(3):188-200 [PMID: 36654776]
  44. Diabetes Technol Ther. 2005 Feb;7(1):115-23 [PMID: 15738709]
  45. Expert Opin Biol Ther. 2020 Aug;20(8):887-897 [PMID: 32299257]
  46. ACS Sens. 2025 Jan 24;10(1):254-263 [PMID: 39742419]
  47. Dermatol Online J. 2016 Aug 15;22(8): [PMID: 27617934]
  48. ACS Appl Mater Interfaces. 2023 Jul 12;15(27):32240-32250 [PMID: 37368956]
  49. Int J Surg Case Rep. 2024 Mar;116:109374 [PMID: 38401324]
  50. Wound Repair Regen. 2016 Nov;24(6):1097-1102 [PMID: 27607352]
  51. Int J Nanomedicine. 2024 Jun 21;19:6281-6293 [PMID: 38919772]
  52. Pharmaceutics. 2023 Mar 19;15(3): [PMID: 36986847]
  53. Adv Mater. 2022 Feb;34(8):e2107205 [PMID: 34873762]
  54. Curr Pharm Des. 2022;28(39):3175-3193 [PMID: 35676840]
  55. Bioact Mater. 2022 Mar 22;18:213-227 [PMID: 35387166]
  56. J Pharm Sci. 2016 May;105(5):1733-1740 [PMID: 27012226]
  57. Sensors (Basel). 2024 Oct 11;24(20): [PMID: 39460030]
  58. ACS Sens. 2024 Apr 26;9(4):2183-2193 [PMID: 38588327]
  59. Front Bioeng Biotechnol. 2022 Nov 25;10:1060026 [PMID: 36507270]
  60. Biofabrication. 2023 Oct 10;16(1): [PMID: 37751750]
  61. Theranostics. 2024 Jan 1;14(2):547-570 [PMID: 38169658]
  62. Brain Res Bull. 2019 May;148:25-33 [PMID: 30898579]
  63. Front Immunol. 2023 Jul 27;14:1216321 [PMID: 37575261]
  64. Biomater Adv. 2022 Apr;135:212746 [PMID: 35929218]
  65. Int J Pharm. 2004 Jun 11;277(1-2):91-7 [PMID: 15158972]
  66. ACS Nano. 2024 Sep 10;18(36):24605-24616 [PMID: 39185844]
  67. Cell Reprogram. 2022 Feb;24(1):38-47 [PMID: 35119303]
  68. Biomater Adv. 2022 Apr;135:212737 [PMID: 35929210]
  69. Front Immunol. 2021 Sep 14;12:712781 [PMID: 34594328]
  70. J Control Release. 2008 May 22;128(1):80-8 [PMID: 18394741]
  71. Acta Diabetol. 2023 Feb;60(2):151-161 [PMID: 35994106]
  72. Biomater Sci. 2023 Apr 11;11(8):2750-2758 [PMID: 36876633]
  73. NPJ Digit Med. 2019 Sep 6;2:88 [PMID: 31508498]
  74. J Hazard Mater. 2024 Oct 5;478:135462 [PMID: 39126854]
  75. J Biomed Mater Res A. 2023 Jul;111(7):910-920 [PMID: 36861657]
  76. Nanomaterials (Basel). 2024 Jun 26;14(13): [PMID: 38998702]
  77. Tissue Eng Regen Med. 2021 Oct;18(5):713-734 [PMID: 34048000]
  78. Diabetes Technol Ther. 2009 Jun;11(6):329-37 [PMID: 19459760]
  79. Int J Nanomedicine. 2023 May 22;18:2707-2720 [PMID: 37250470]
  80. Regen Ther. 2024 May 29;26:102-113 [PMID: 38872978]
  81. Chembiochem. 2023 Apr 3;24(7):e202200672 [PMID: 36719179]
  82. J Mater Chem B. 2020 Oct 21;8(40):9335-9342 [PMID: 32969458]
  83. Cureus. 2024 Feb 28;16(2):e55193 [PMID: 38562272]
  84. Theranostics. 2022 Jan 3;12(4):1537-1556 [PMID: 35198056]
  85. Biomed Opt Express. 2021 Mar 22;12(4):2221-2235 [PMID: 33996225]
  86. Micromachines (Basel). 2021 Mar 25;12(4): [PMID: 33806024]
  87. Front Endocrinol (Lausanne). 2017 Jan 24;8:6 [PMID: 28167928]
  88. Mater Today Bio. 2023 Apr 15;20:100638 [PMID: 37128286]
  89. Biosensors (Basel). 2021 Dec 03;11(12): [PMID: 34940251]
  90. Materials (Basel). 2021 Jul 16;14(14): [PMID: 34300896]
  91. Curr Pharm Des. 2019;25(2):166-173 [PMID: 30848184]
  92. Cell. 2014 Oct 9;159(2):428-39 [PMID: 25303535]
  93. J Diabetes Sci Technol. 2024 Mar 20;:19322968241236211 [PMID: 38506487]
  94. Drug Deliv Transl Res. 2022 May;12(5):973-980 [PMID: 33851362]
  95. J Biomater Sci Polym Ed. 2024 Jun;35(8):1236-1257 [PMID: 38460114]
  96. Front Genet. 2018 Nov 21;9:535 [PMID: 30524468]
  97. Pharm Res. 2006 Jan;23(1):104-13 [PMID: 16308670]
  98. Materials (Basel). 2023 Sep 01;16(17): [PMID: 37687713]
  99. Pharmaceutics. 2024 Nov 12;16(11): [PMID: 39598565]
  100. Behav Anal Pract. 2021 May 3;14(4):1191-1208 [PMID: 34868822]
  101. Eur J Pharm Sci. 2022 May 1;172:106148 [PMID: 35189271]
  102. ACS Nano. 2023 Jul 25;17(14):14161-14175 [PMID: 37406357]
  103. Nutrients. 2024 Jan 04;16(1): [PMID: 38202002]
  104. Biomater Sci. 2023 Sep 12;11(18):6109-6115 [PMID: 37591802]
  105. ACS Biomater Sci Eng. 2018 Jul 9;4(7):2226-2236 [PMID: 33435098]
  106. Biotechnol Lett. 2022 Nov;44(11):1243-1261 [PMID: 36242675]
  107. Front Endocrinol (Lausanne). 2023 Jan 11;13:1074568 [PMID: 36714604]
  108. Biomolecules. 2023 Feb 27;13(3): [PMID: 36979379]
  109. Curr Diabetes Rev. 2024;21(2):e270224227477 [PMID: 38424430]
  110. Int J Mol Sci. 2022 Aug 08;23(15): [PMID: 35955934]
  111. Diabetes Care. 2014 Jan;37 Suppl 1:S81-90 [PMID: 24357215]
  112. Burns Trauma. 2023 Feb 07;11:tkac058 [PMID: 36761088]
  113. Diagnostics (Basel). 2020 Mar 03;10(3): [PMID: 32138353]
  114. Nanotechnology. 2020 Sep 25;31(39):395601 [PMID: 32554896]
  115. Polymers (Basel). 2020 Oct 06;12(10): [PMID: 33036130]
  116. Biomater Sci. 2022 Mar 29;10(7):1626-1646 [PMID: 35230359]
  117. Digit Health. 2024 Dec 10;10:20552076241300748 [PMID: 39659398]
  118. J Mater Chem B. 2019 Aug 21;7(33):5019-5037 [PMID: 31432870]
  119. Sensors (Basel). 2020 Jun 23;20(12): [PMID: 32586032]
  120. J Diabetes Sci Technol. 2025 Jan;19(1):161-164 [PMID: 37401788]
  121. Carbohydr Polym. 2023 Aug 1;313:120512 [PMID: 37182929]
  122. Biomaterials. 2021 Jan;267:120458 [PMID: 33197650]
  123. Transl Res. 2019 Nov;213:1-22 [PMID: 31194942]
  124. Diabetologia. 2025 Feb;68(2):255-280 [PMID: 39653802]
  125. J Colloid Interface Sci. 2022 Sep 15;622:87-96 [PMID: 35489104]
  126. Nanoscale. 2023 Dec 21;16(1):163-170 [PMID: 38073477]
  127. Nanomaterials (Basel). 2022 Jan 06;12(2): [PMID: 35055196]
  128. Int J Pharm. 2025 Feb 10;670:125128 [PMID: 39722375]
  129. Ther Deliv. 2022 Dec;13(12):591-604 [PMID: 36861306]
  130. Biomed Microdevices. 2019 Dec 3;22(1):2 [PMID: 31797133]
  131. Biosensors (Basel). 2023 Sep 27;13(10): [PMID: 37887102]
  132. Cureus. 2024 Nov 7;16(11):e73236 [PMID: 39651019]
  133. Talanta. 2025 Jan 1;282:127003 [PMID: 39406102]
  134. Adv Drug Deliv Rev. 2012 Nov;64(14):1547-68 [PMID: 22575858]
  135. Stem Cell Res Ther. 2022 Aug 20;13(1):428 [PMID: 35987697]
  136. J Clin Transl Sci. 2020 Sep 22;5(1):e51 [PMID: 33948272]
  137. ACS Appl Bio Mater. 2025 Jan 20;8(1):475-487 [PMID: 39718458]
  138. ACS Sens. 2021 Mar 26;6(3):871-880 [PMID: 33720705]
  139. Macromol Biosci. 2024 Mar;24(3):e2300217 [PMID: 37831962]
  140. ACS Appl Mater Interfaces. 2024 Sep 11;16(36):47973-47987 [PMID: 39225263]
  141. Eur Rev Med Pharmacol Sci. 2022 Apr;26(7):2415-2421 [PMID: 35442496]
  142. Clin Exp Gastroenterol. 2023 Dec 14;16:249-276 [PMID: 38111516]
  143. J Med Eng Technol. 2023 Feb;47(2):121-130 [PMID: 35895023]
  144. Int J Low Extrem Wounds. 2024 Dec;23(4):568-576 [PMID: 35188432]
  145. Front Chem. 2022 Aug 11;10:944428 [PMID: 36034672]
  146. Prog Polym Sci. 2016 Feb 1;53:86-168 [PMID: 27022202]
  147. Front Bioeng Biotechnol. 2024 Mar 27;12:1309541 [PMID: 38600945]
  148. ACS Biomater Sci Eng. 2019 Nov 11;5(11):5781-5789 [PMID: 33405670]
  149. Mol Biol Rep. 2023 Jun;50(6):5355-5367 [PMID: 37029875]
  150. World J Diabetes. 2024 Jun 15;15(6):1142-1161 [PMID: 38983831]
  151. Int J Biol Macromol. 2025 Jan;284(Pt 1):137955 [PMID: 39592049]
  152. Nanoscale. 2018 May 24;10(20):9547-9560 [PMID: 29745944]
  153. IEEE Trans Biomed Circuits Syst. 2020 Jun;14(3):504-515 [PMID: 32149655]
  154. Acta Biomater. 2023 Jan 1;155:199-217 [PMID: 36402298]
  155. Adv Healthc Mater. 2016 Nov;5(22):2841-2855 [PMID: 27709832]
  156. ACS Sens. 2023 Apr 28;8(4):1710-1722 [PMID: 36988576]
  157. Int J Artif Organs. 2024 Mar;47(3):129-139 [PMID: 38253541]
  158. Materials (Basel). 2023 Aug 03;16(15): [PMID: 37570163]
  159. Biomaterials. 2023 Nov;302:122315 [PMID: 37689048]
  160. Biomater Res. 2022 Feb 2;26(1):4 [PMID: 35109931]
  161. J Mater Chem B. 2024 Jul 17;12(28):6774-6804 [PMID: 38920094]
  162. Int J Pharm. 2009 Jun 22;375(1-2):107-13 [PMID: 19481696]
  163. Carbohydr Polym. 2022 Feb 15;278:118999 [PMID: 34973801]
  164. J Clin Transl Sci. 2020 Jul 14;5(1):e19 [PMID: 33948242]
  165. Pharmaceutics. 2021 Mar 19;13(3): [PMID: 33808901]
  166. Tissue Eng Regen Med. 2016 Oct 20;13(5):475-484 [PMID: 30603429]
  167. PLoS One. 2024 Jun 17;19(6):e0298124 [PMID: 38885218]
  168. Arch Microbiol. 2024 Apr 2;206(4):199 [PMID: 38563993]
  169. Int J Biol Macromol. 2021 Sep 1;186:656-685 [PMID: 34271047]
  170. ACS Appl Bio Mater. 2024 Oct 21;7(10):6603-6616 [PMID: 39250682]
  171. Adv Drug Deliv Rev. 2018 Mar 1;127:119-137 [PMID: 29604374]
  172. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Sep;8(5):696-716 [PMID: 26762467]
  173. Adv Sci (Weinh). 2024 Aug;11(31):e2401386 [PMID: 38894575]
  174. J Pediatr Pharmacol Ther. 2019 Mar-Apr;24(2):99-106 [PMID: 31019402]
  175. ACS Biomater Sci Eng. 2025 Jan 13;11(1):371-382 [PMID: 39698967]
  176. Diabetologia. 2023 Feb;66(2):300-309 [PMID: 36411396]
  177. ACS Biomater Sci Eng. 2018 May 14;4(5):1770-1778 [PMID: 30345348]
  178. J Nanobiotechnology. 2024 May 16;22(1):258 [PMID: 38755644]
  179. Drug Deliv. 2024 Dec;31(1):2296350 [PMID: 38147499]
  180. Bioengineering (Basel). 2024 Feb 14;11(2): [PMID: 38391669]
  181. Discov Mater. 2022;2(1):12 [PMID: 36536830]
  182. Wound Repair Regen. 2020 Nov;28(6):751-771 [PMID: 32861223]
  183. Drug Dev Ind Pharm. 2021 Nov;47(11):1713-1732 [PMID: 35332822]
  184. Pharmaceutics. 2024 Dec 09;16(12): [PMID: 39771551]
  185. Mol Cell Endocrinol. 2018 Dec 5;477:70-80 [PMID: 29913182]
  186. Mol Biotechnol. 2024 Dec;66(12):3415-3437 [PMID: 37987985]
  187. Eur J Pharm Biopharm. 2025 Jan;206:114586 [PMID: 39613270]
  188. J Breath Res. 2014 Nov 24;8(4):046008 [PMID: 25417653]
  189. J Biomed Inform. 2022 Mar;127:104009 [PMID: 35196579]
  190. J Mater Chem B. 2023 May 3;11(17):3766-3786 [PMID: 37039297]
  191. Biotechnol Adv. 2017 Sep;35(5):530-544 [PMID: 28558979]
  192. Diabetes. 2009 Apr;58(4):773-95 [PMID: 19336687]
  193. Sensors (Basel). 2022 Jan 14;22(2): [PMID: 35062598]
  194. Int J Nanomedicine. 2020 Dec 03;15:9717-9743 [PMID: 33299313]
  195. Int J Biol Macromol. 2023 Jul 1;242(Pt 2):124915 [PMID: 37211080]
  196. J Mater Chem B. 2022 Sep 28;10(37):7591-7599 [PMID: 35587736]
  197. Endocr Metab Immune Disord Drug Targets. 2024;24(6):626-641 [PMID: 37817658]
  198. Crit Rev Oncog. 2019;24(3):213-222 [PMID: 32422019]
  199. Nanomaterials (Basel). 2023 Mar 24;13(7): [PMID: 37049255]
  200. Int Wound J. 2023 Sep;20(7):2924-2941 [PMID: 36924081]
  201. Sensors (Basel). 2021 Aug 17;21(16): [PMID: 34450960]
  202. Adv Exp Med Biol. 2019;1192:199-224 [PMID: 31705496]
  203. Diabetes Care. 2001 Aug;24(8):1502-3 [PMID: 11473098]
  204. Drug Deliv Transl Res. 2021 Aug;11(4):1675-1688 [PMID: 33710589]
  205. Anal Chem. 2024 Apr 23;96(16):6158-6169 [PMID: 38602477]
  206. NASN Sch Nurse. 2019 Mar;34(2):86-89 [PMID: 30382764]
  207. ACS Sens. 2025 Feb 28;10(2):699-708 [PMID: 39365950]
  208. Curr Pharm Biotechnol. 2024 Jul 12;: [PMID: 39005117]
  209. Indian J Endocrinol Metab. 2022 Mar-Apr;26(2):106-110 [PMID: 35873934]
  210. Biol Trace Elem Res. 2023 Jan;201(1):306-323 [PMID: 35237941]
  211. Biosensors (Basel). 2023 Nov 18;13(11): [PMID: 37998164]
  212. Int J Biol Macromol. 2023 Dec 31;253(Pt 2):126680 [PMID: 37673151]
  213. Front Endocrinol (Lausanne). 2021 Mar 16;12:636959 [PMID: 33796074]
  214. Int J Mol Sci. 2024 Jan 17;25(2): [PMID: 38256225]
  215. Diabetes Metab Syndr. 2025 Jan;19(1):103170 [PMID: 39689387]
  216. Adv Drug Deliv Rev. 2007 Jul 30;59(7):617-30 [PMID: 17597252]
  217. ACS Appl Mater Interfaces. 2024 Sep 25;16(38):51669-51678 [PMID: 39268841]
  218. J Diabetes Complications. 2021 Aug;35(8):107929 [PMID: 33902999]
  219. Int J Biol Macromol. 2022 May 31;208:400-408 [PMID: 35248609]
  220. Stem Cell Res Ther. 2024 Aug 15;15(1):262 [PMID: 39148112]
  221. Adv Sci (Weinh). 2024 Mar;11(10):e2307746 [PMID: 38145346]
  222. Adv Healthc Mater. 2024 Sep;13(23):e2400881 [PMID: 38781005]
  223. J Breath Res. 2013 Sep;7(3):037110 [PMID: 23959908]
  224. Bioengineering (Basel). 2023 Feb 06;10(2): [PMID: 36829712]
  225. Gels. 2023 Oct 30;9(11): [PMID: 37998956]
  226. Int J Pharm. 2019 Jul 20;566:307-328 [PMID: 31125714]
  227. Biomater Sci. 2025 Jan 14;13(2):379-407 [PMID: 39620710]
  228. J Surg Res. 2023 Jan;281:200-213 [PMID: 36191376]
  229. Neural Comput Appl. 2023;35(20):14565-14576 [PMID: 34539091]
  230. Front Cell Dev Biol. 2023 Feb 27;11:1029671 [PMID: 36923255]
  231. Chonnam Med J. 2023 May;59(2):109-114 [PMID: 37303819]
  232. Int J Biol Macromol. 2020 Mar 15;147:160-169 [PMID: 31904459]
  233. Molecules. 2023 Jan 22;28(3): [PMID: 36770776]
  234. Cureus. 2024 Jun 13;16(6):e62324 [PMID: 39006724]
  235. Pharmaceutics. 2023 Feb 14;15(2): [PMID: 36839966]
  236. Med Devices Sens. 2021 Feb;4(1):e10161 [PMID: 33615149]
  237. Trends Endocrinol Metab. 2021 Aug;32(8):609-622 [PMID: 34154916]
  238. J Am Med Dir Assoc. 2024 Aug;25(8):105036 [PMID: 38796168]
  239. Adv Drug Deliv Rev. 2006 Nov 15;58(11):1258-68 [PMID: 17079049]
  240. J Clin Transl Res. 2022 Nov 09;8(6):488-498 [PMID: 36451998]
  241. Front Bioinform. 2022 Apr;2: [PMID: 35600765]
  242. Diabetologia. 2021 May;64(5):1016-1029 [PMID: 33710398]
  243. Sci Rep. 2020 Feb 24;10(1):3307 [PMID: 32094395]
  244. Curr Diabetes Rev. 2013 Jul;9(4):294-311 [PMID: 23721158]
  245. J Biomed Mater Res B Appl Biomater. 2022 Nov;110(11):2542-2573 [PMID: 35579269]
  246. Pharmaceuticals (Basel). 2024 Sep 30;17(10): [PMID: 39458946]
  247. Polymers (Basel). 2022 Jan 25;14(3): [PMID: 35160466]
  248. Rev Sci Tech. 2019 May;38(1):279-289 [PMID: 31564722]
  249. J Mater Chem B. 2020 Aug 26;8(33):7303-7318 [PMID: 32647855]
  250. Front Endocrinol (Lausanne). 2023 Aug 17;14:1221705 [PMID: 37664860]
  251. Crit Rev Immunol. 2019;39(4):239-265 [PMID: 32421967]
  252. Prosthet Orthot Int. 2015 Feb;39(1):29-39 [PMID: 25614499]
  253. Mater Today Bio. 2022 Dec 01;18:100508 [PMID: 36504542]
  254. ACS Appl Bio Mater. 2023 May 15;6(5):1774-1786 [PMID: 37058290]
  255. Adv Healthc Mater. 2019 Jun;8(12):e1900423 [PMID: 31111686]
  256. J Biomed Mater Res B Appl Biomater. 2023 Sep;111(9):1629-1639 [PMID: 37166150]
  257. Biomimetics (Basel). 2024 May 04;9(5): [PMID: 38786486]
  258. Anal Chem. 2024 Dec 24;96(51):20197-20203 [PMID: 39670582]
  259. J Leukoc Biol. 2015 Dec;98(6):953-62 [PMID: 26168797]
  260. Int J Pharm. 2007 Aug 1;340(1-2):134-42 [PMID: 17459620]
  261. Int J Nanomedicine. 2022 Dec 05;17:6007-6029 [PMID: 36506345]
  262. Sensors (Basel). 2013 Apr 11;13(4):4811-40 [PMID: 23580051]
  263. Gene. 2021 Feb 5;768:145288 [PMID: 33181259]
  264. Int J Pharm. 2021 Mar 1;596:120297 [PMID: 33508345]
  265. Front Chem. 2024 Nov 20;12:1469183 [PMID: 39635576]
  266. Analyst. 2025 Jan 27;150(3):505-512 [PMID: 39745085]
  267. Adv Wound Care (New Rochelle). 2014 Feb 1;3(2):91-97 [PMID: 24761349]

Word Cloud

Created with Highcharts 10.0.0diabetesbiomaterialstreatmentmanagementresearchreviewDiabeteswidespreadmetabolicdisorderpresentsconsiderablechallengesRecentadvancementsbiomaterialshedlightinnovativeapproachesexaminesrolediagnosiswellapplicationmanagingdiabeticwoundsevaluatingrecentdevelopmentsalongsidefutureobstacleshighlightspromisingpotentialcareunderscoringimportanceenhancingpatientoutcomesrefiningmethodologiesApplicationsprospectsbiosensorsinsulindeliverytissueengineering

Similar Articles

Cited By

No available data.